|
|
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ...
gene112: 金币+250, 翻译EPI+1, ★★★★★最佳答案 2012-05-20 20:04:53
With the global spread of the Ageing of Population, the social transformation and the evolution of human lifestyles, the incidence and disability rate of vascular dementia has increased year by year, which brought enormous sufferings and economic burdens to the patients, their families and the society. Both modern medicine and the motherland medicine have obtained the remarkable progress in the treatment of this disease, however there are still inadequacies, therefore the study of new prevention and control strategies is badly needed. As a safe and effective cell nutrient, soy isoflavones have made great progress in the clinical and basic research on the cerebrovascular diseases and neurodegenerative changes. The preliminary research of the project group suggested that soy isoflavones had a significant improvement in the behavioral abnormalities of vascular dementia rats, thus it is necessary to do the relevant clinical research.
This project aims to observe the efficacy of soy isoflavones on vascular dementia and to lay a research base for its promotion and application, via the strict, standardized, prospective, randomized, controlled, single - blind clinical trials. The expected results include: (1) To confirm the efficacy of soy isoflavone in the treatment of vascular dementia; (2) To publish 1-2 articles in core journals based on the research results. |
|
回复此楼